| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |